Avelo’s device makes the diagnosis of respiratory infections easier and more reliable.
Avelo has raised €2.4M across 2 funding rounds from 5 investors, most recently a Seed round in Sep 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-09-20 | Seed | €2.3M | Angel Investors,Arve Capital,OCCIDENT,Privilège Ventures,Zürcher Kantonalbank | View deal → |
| 2022-06-22 | Other | €148k | — | View deal → |
